Acute levodopa administration reduces cortisol release in patients with Parkinson's disease

Journal of Neural Transmission

Volumn 114, Issue 3, 2007, Pages 347-350

  Muller T ^a   Welnic, J ^a   Muhlack, S ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Cortisol; Levodopa; Parkinson's disease

Indexed keywords

3 O METHYLDOPA; BENSERAZIDE PLUS LEVODOPA; HYDROCORTISONE; LEVODOPA; MADOPAR LT; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; AGED; ARTICLE; BLOOD LEVEL; BRAIN STEM; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG USE; HUMAN; HYDROCORTISONE RELEASE; LONG TERM CARE; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; ANTIPARKINSON AGENTS; BENSERAZIDE; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEVODOPA; MALE; MIDDLE AGED; NEURAL PATHWAYS; PARKINSON DISEASE; RAPHE NUCLEI; SEROTONIN; TYROSINE;

EID: 33847322535     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0552-0     Document Type: Article

References (20)

1. H Braak U Rub WP Gai K Del Tredici 2003 Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen J Neural Transm 110 517 536
2. D Garcia-Borreguero O Larrosa JJ Granizo LY de la WA Hening 2004 Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome Sleep 27 669 673
3. GM Halliday PC Blumbergs RG Cotton WW Blessing LB Geffen 1990 Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease Brain Res 510 104 107
4. S Happe T Tings K Helmschmied K Neubert W Wuttke W Paulus C Trenkwalder 2004 Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease Mov Disord 19 1511 1515
5. E Hoglund N Kolm S Winberg 2001 Stress-induced changes in brain serotonergic activity, plasma cortisol and aggressive behavior in Arctic charr (Salvelinus alpinus) is counteracted by L-DOPA Physiol Behav 74 381 389
6. KP Lesch A Hoh HM Schulte M Osterheider T Müller 1991 Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder Psychopharmacology (Berl) 105 415 420
7. KP Lesch M Wiesmann A Hoh T Müller J Disselkamp-Tietze M Osterheider HM Schulte 1992 5-HT1A receptor-effector system responsivity in panic disorder Psychopharmacology (Berl) 106 111 117
8. A Lopez A Munoz MJ Guerra JL Labandeira-Garcia 2001 Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum Neuroscience 103 639 651
9. E Melamed F Hefti DJ Pettibone J Liebman RJ Wurtman 1981 Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism Neurology 31 651 655
10. E Melamed F Hefti RJ Wurtman 1980 Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism Ann Neurol 8 558 563
11. S Muhlack D Woitalla J Welnic S Twiehaus H Przuntek T Müller 2004 Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease Neurosci Lett 363 284 287
12. T Müller C Erdmann S Muhlack D Bremen H Przuntek D Woitalla 2006 Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels Mov Disord 21 332 336
13. P Osei-Owusu A James J Crane KE Scrogin 2005 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome J Pharmacol Exp Ther 313 1324 1330
14. H Philippi J Pohlenz W Grimm T Koffler W Schonberger 2000 Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature Acta Paediatr 89 442 446
15. B Sabbe W Hulstijn M Maes M Pier S Scharpe F Zitman 2004 Psychomotor, neuroendocrine and behavioural effects after oral administration of levodopa in normal volunteers Psychiatry Res 128 103 106
16. C Schüle TC Baghai D Eser P Zwanzger M Jordan R Buechs R Rupprecht 2006 Time course of hypothalamic-pituitary-adrenocoertical axis activity during treatment with reboxitine and mirtazapine in depressed patients Psychopharmacology 186 601 611
17. GJ Vega RA Miranda G Martinez MV Torrero dJ Lopez 2003 Hyperpigmentation mimicking Laugier syndrome, levodopa therapy and Addison's disease J Eur Acad Dermatol Venereol 17 324 327
18. B Vizner Z Reiner M Sekso 1983 Effect of L-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects Exp Clin Endocrinol 81 41 48
19. HP Vogel R Ketsche 1986 Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy J Neurol 233 149 152
20. R Volpi P Caffarra A Scaglioni D Maestri P Chiodera V Coiro 1994 Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease J Neural Transm Park Dis Dement Sect 7 1 11